The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.
About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...
A research team co-led by scientists at the University of Arizona College of Medicine – Tucson found that an osteoporosis drug might counter a rare genetic mutation underlying a type of heart disease.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
A newborn baby who died in a Glasgow hospital after developing an infection was “stable” the day before she passed away, an ...
IRH linked to incident heart failure, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction ...
A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...
The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback